Drug makes leukemia more vulnerable to chemo

A new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells, according to John F. DiPersio, MD, PhD, and his colleagues at Washington University. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.

Progress in fight against aggressive childhood leukemia

Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome.